research Psoriatic Skin Lesions Induced by Certolizumab Pegol
This document provides a legal disclaimer and offers no research findings.
Search
forResearch
5 / 75 results 
research Paradoxical Skin Reaction to Certolizumab, an Overlap of Pyoderma Gangrenosum and Psoriasis in a Young Woman Treated for Ankylosing Spondylitis: Case Report with Literature Review
This case report describes a young woman with ankylosing spondylitis who developed a severe paradoxical skin reaction after six months on certolizumab, requiring treatment with secukinumab and methotrexate.
research Psoriatic Alopecia and Paradoxical Psoriasis Induced by Adalimumab Successfully Treated with Certolizumab: Clinical, Trichoscopic, and in vivo Reflectance Confocal Microscopy Features
This study found that among anti-TNF-α agents, certolizumab is the least likely to cause paradoxical reactions such as psoriatic alopecia and appears to be an effective and safe option for managing psoriasis and PsA while minimizing these risks.
research Alopecia induced by tumour necrosis factor-alpha antagonists: description of 52 cases and disproportionality analysis in a nationwide pharmacovigilance database
This study confirms an association between TNF-α antagonist exposure and alopecia, indicating a class effect among the medications examined.
research Ottawa, Ontario, Canada, February 13–16, 2013
This abstract describes a program with various presentations and events focused on Canadian excellence in rheumatology but reports no new research findings.
Learn
— no results
Community Join
— no results
Experts
— no results
Clinics
— no results